EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy

Xing Ma iD, Yangyang Zhou, Ruping Li, Xianmin Ding, Deyu Li, Tingting Pan, Fuqiang Zhang, Wenliang Li

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23791 ↗

At a glance

Übersichtsarbeit in Molecular Carcinogenesis, 2024. Written by Xing Ma and 7 co-authors. Institution: Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. Major MEDLINE topics: Cholangiocarcinoma, Bile Duct Neoplasms, Protein Serine-Threonine Kinases, Hippo Signaling Pathway. Cited 1 times so far (Crossref); 67 references. Funded by: Henan Medical Science and Technology Breakthrough Plan.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The tumorigenesis of intrahepatic cholangiocarcinoma (ICC) has been identified to be exceptionally involved in dysregulated Hippo/Yes‐associated protein (YAP) signaling pathway (Hippo/YAP). Hippo/YAP functions as a master regulator engaged in a plethora of physiological and oncogenic processes as well. Therefore, the aberrant Hippo/YAP could serve as an Achilles' heel regarding the molecular therapeutic avenues for ICC patients. Herein, we comprehensively review the recent studies about the underlying mechanism of disrupted Hippo/YAP in ICC, how diagnostic values could be utilized upon the critical genes in this pathway, and what opportunities could be given upon this target pathway.

Subjects

MeSH terms (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsProtein Serine-Threonine KinasesHippo Signaling PathwayTranscription FactorsSignal TransductionYAP-Signaling ProteinsHumansAdaptor Proteins, Signal TransducingAnimalsMolecular Targeted TherapyGene Expression Regulation, Neoplastic

Author keywords

Hippo/YAPHippo/Yes‐associated proteindiagnosisintrahepatic cholangiocarcinomatherapy

Substances

Protein Serine-Threonine KinasesTranscription FactorsYAP-Signaling ProteinsYAP1 protein, humanAdaptor Proteins, Signal Transducing

Authors and institutions

  • Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID profiles: Xing Ma

Funding

  • Henan Medical Science and Technology Breakthrough Plan

Cite

APA

Ma, X., Zhou, Y., Li, R., Ding, X., Li, D., Pan, T., Zhang, F., & Li, W. (2024). Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23791

Vancouver

Ma X, Zhou Y, Li R, Ding X, Li D, Pan T, et al. Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23791

BibTeX
@article{Ma2024,
  author = {Ma, Xing and Zhou, Yangyang and Li, Ruping and Ding, Xianmin and Li, Deyu and Pan, Tingting and Zhang, Fuqiang and Li, Wenliang},
  title = {Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23791}
}
Start for free →